- In re EpiPen Marketing, Sales Practices and Antitrust Litigation
If you purchased or paid for an EpiPen® or EpiPen Jr® at any time between August 24, 2011 and November 1, 2020, your rights will be affected by this class action settlement with the Pfizer Defendants
- UNITED STATES DISTRICT COURT - epipenclassaction. com
This Notice relates to a proposed Settlement of claims in a pending class action alleging that Mylan violated certain state antitrust, federal racketeering, and other laws in the United States, harming competition and causing Class Members to overpay for EpiPen products
- Microsoft Word - FINAL_EPIPEN PFIZER STIPULATION OF CLASS ACTION . . .
1 1 “Action” means In re EpiPen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation, Civil Action No 2:17-md-02785-DDC-TJJ (MDL No 2785)
- Microsoft Word - EpiPen LF Notice (004) FINAL
This Notice relates to a proposed Settlement of claims in a pending class action alleging that the Pfizer Defendants violated certain state antitrust and federal racketeering laws in the United States, harming competition and causing Class Members to overpay for EpiPen products
- Microsoft Word - EpiPen Long Form Notice - FINAL 10-17-20
Plaintiffs in this lawsuit claim that Defendants violated certain state antitrust and federal racketeering laws in the United States, harming competition and causing class members to overpay for EpiPen products
- Microsoft Word - EpiPen Consumer Claim Form 080321 FINAL
I certify that I, or the Class Member I represent, paid the total amount set forth above in out‐of‐pocket expenditures for purchases or reimbursements of Branded or authorized generic versions of EpiPen prescriptions between August 24, 2011, and November 1, 2020, inclusive
- UNITED STATES DISTRICT COURT - epipenclassaction. com
Co-Lead Counsel and Liaison Counsel for Class Plaintiffs HOGAN LOVELLS US LLP By: s Adam K Levin David M Foster Carolyn A DeLone Kathryn M Ali 555 13th Street, NW Washington, DC 20004 Telephone: (202) 637-5600 Fax: (202) 637-5910 adam levin@hoganlovells com and LATHROP GPM LLP
- UNITED STATES DISTRICT COURT DISTRICT OF KANSAS In re EPIPEN . . .
Plaintiffs, individually and on behalf of all others similarly situated, bring this Consolidated Class Action Complaint against Defendants Mylan N V ; Mylan Specialty L P ; Mylan Pharmaceuticals, Inc ; Heather Bresch; Pfizer, Inc ; King Pharmaceuticals, Inc ; and Meridian )
|